FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896046463> ?p ?o ?g. }

• W2896046463 abstract "Oncogenic viruses are responsible by development of tumors as Human papillomavirus (HPV) that infect the anogenital epithelium causing cervical cancer, anal and penis cancer. There are viral groups based on their oncogenic activity as high‒risk types, low‒risk types and types of undetermined‒risk. Several biotechnological assays are based on the production of recombinant products originated by the interaction of a viral genome with the genome of a host cell as bacteria, yeast, cell cultures and insects. Recently have been used virus‒like particles (VLP) independently of the viral genome since some viral particles have the ability to self‒assembling. There are some approved VLP vaccines as HPV vaccines, Hepatitis B and E vaccines and other VLP based vaccines under development such as using Human B19 parvovirus‒like particles, Influenza vaccine candidates, Norwalk virus, Ebola and Marbug virus, Hepatitis C, Human immunodeficiency virus (HIV) as vaccine candidates. The aim of this present study was to address some examples of virus causing tumors and their respective recombinant protein based virus‒like particle vaccines. Besides of HPV, also will also be addressed Hepatitis C virus (HCV), Hepatitis B virus (HBV), Herpesvirus (HSV), Herpes Simplex Virus (HSV‒1) and Herpes Simplex Virus (HSV‒2), Human Herpesvirus 3 (HHV‒3), Human Herpesvirus 4 (HHV‒4) or Epstain‒Barr virus (EBV), Human Herpesvirus‒5 (HHV‒5) or Human Cytomegalovirus (HCMV), Human Herpesvirus 6 (HHV‒6), Human Herpesvirus 7 (HHV‒7) and Human Herpesvirus 8 (HHV‒8), also known as Kaposi’s sarcoma‒associated herpesvirus (KSHV). There are several challenges in the production of the virus‒like particles based recombinant vaccines under development using specific cell lines and assays with laboratory animals. It is important to reflect about on the extent to which the pharmaceutical industries are willing to develop recombinant vaccines in the prevention of tumor associated diseases." @default.
• W2896046463 created "2018-10-26" @default.
• W2896046463 creator A5012306113 @default.
• W2896046463 creator A5025741554 @default.
• W2896046463 date "2018-05-16" @default.
• W2896046463 modified "2023-10-17" @default.
• W2896046463 title "Tumors associated with oncogenic viruses and recombinant vaccines" @default.
• W2896046463 cites W1656291587 @default.
• W2896046463 cites W173539739 @default.
• W2896046463 cites W1986470238 @default.
• W2896046463 cites W2007533505 @default.
• W2896046463 cites W2024501020 @default.
• W2896046463 cites W2038627470 @default.
• W2896046463 cites W2059831390 @default.
• W2896046463 cites W2060807469 @default.
• W2896046463 cites W2071862102 @default.
• W2896046463 cites W2086854288 @default.
• W2896046463 cites W2104604425 @default.
• W2896046463 cites W2409598223 @default.
• W2896046463 cites W2476981796 @default.
• W2896046463 cites W2568896114 @default.
• W2896046463 cites W275762966 @default.
• W2896046463 cites W2782869379 @default.
• W2896046463 doi "https://doi.org/10.15406/jabb.2018.05.00131" @default.
• W2896046463 hasPublicationYear "2018" @default.
• W2896046463 type Work @default.
• W2896046463 sameAs 2896046463 @default.
• W2896046463 citedByCount "0" @default.
• W2896046463 crossrefType "journal-article" @default.
• W2896046463 hasAuthorship W2896046463A5012306113 @default.
• W2896046463 hasAuthorship W2896046463A5025741554 @default.
• W2896046463 hasBestOaLocation W28960464631 @default.
• W2896046463 hasConcept C104317684 @default.
• W2896046463 hasConcept C159047783 @default.
• W2896046463 hasConcept C16184334 @default.
• W2896046463 hasConcept C2522874641 @default.
• W2896046463 hasConcept C40767141 @default.
• W2896046463 hasConcept C54355233 @default.
• W2896046463 hasConcept C86803240 @default.
• W2896046463 hasConceptScore W2896046463C104317684 @default.
• W2896046463 hasConceptScore W2896046463C159047783 @default.
• W2896046463 hasConceptScore W2896046463C16184334 @default.
• W2896046463 hasConceptScore W2896046463C2522874641 @default.
• W2896046463 hasConceptScore W2896046463C40767141 @default.
• W2896046463 hasConceptScore W2896046463C54355233 @default.
• W2896046463 hasConceptScore W2896046463C86803240 @default.
• W2896046463 hasIssue "3" @default.
• W2896046463 hasLocation W28960464631 @default.
• W2896046463 hasOpenAccess W2896046463 @default.
• W2896046463 hasPrimaryLocation W28960464631 @default.
• W2896046463 hasRelatedWork W1487857142 @default.
• W2896046463 hasRelatedWork W1965597722 @default.
• W2896046463 hasRelatedWork W1970057644 @default.
• W2896046463 hasRelatedWork W2075870928 @default.
• W2896046463 hasRelatedWork W2088538321 @default.
• W2896046463 hasRelatedWork W2351417972 @default.
• W2896046463 hasRelatedWork W2390587103 @default.
• W2896046463 hasRelatedWork W2407030612 @default.
• W2896046463 hasRelatedWork W2418159135 @default.
• W2896046463 hasRelatedWork W2976520252 @default.
• W2896046463 hasVolume "5" @default.
• W2896046463 isParatext "false" @default.
• W2896046463 isRetracted "false" @default.
• W2896046463 magId "2896046463" @default.
• W2896046463 workType "article" @default.